| Prevalence, diagnosis and outcomes of treatment for primary aldosteronism Y Yang, M Reincke, TA Williams Best Practice & Research Clinical Endocrinology & Metabolism 34 (2), 101365, 2020 | 37 | 2020 |
| Primary aldosteronism: KCNJ5 mutations and adrenocortical cell growth Y Yang, CE Gomez-Sanchez, D Jaquin, ET Aristizabal Prada, LS Meyer, ... Hypertension 74 (4), 809-816, 2019 | 33 | 2019 |
| Classification of microadenomas in patients with primary aldosteronism by steroid profiling Y Yang, J Burrello, A Burrello, G Eisenhofer, M Peitzsch, M Tetti, T Knösel, ... The Journal of steroid biochemistry and molecular biology 189, 274-282, 2019 | 30 | 2019 |
| Diverse responses of autoantibodies to the angiotensin II type 1 receptor in primary aldosteronism TA Williams, D Jaquin, J Burrello, A Philippe, Y Yang, P Rank, N Nirschl, ... Hypertension 74 (4), 784-792, 2019 | 19 | 2019 |
| Treatment of unilateral PA by adrenalectomy: potential reasons for incomplete biochemical cure Y Yang, M Reincke, TA Williams Experimental and Clinical Endocrinology & Diabetes 127 (02/03), 100-108, 2019 | 17 | 2019 |
| Comparative genomics and transcriptome profiling in primary aldosteronism ET Aristizabal Prada, I Castellano, E Sušnik, Y Yang, LS Meyer, M Tetti, ... International journal of molecular sciences 19 (4), 1124, 2018 | 14 | 2018 |
| BEX1 Is Differentially Expressed in Aldosterone-Producing Adenomas and Protects Human Adrenocortical Cells From Ferroptosis Y Yang, M Tetti, T Vohra, C Adolf, J Seissler, M Hristov, A Belavgeni, ... Hypertension 77 (5), 1647-1658, 2021 | 12 | 2021 |
| A novel clinical-imaging nomogram for predicting primary aldosteronism in patients with hypertension Y Liu, M Wang, X Qiu, G Ma, M Ji, Y Yang, M Sun Hypertension Research 46 (12), 2603-2612, 2023 | 3 | 2023 |
| A Prospective Observational Study of Factors Affecting the Change in Quality of Life in Patients With Primary Aldosteronism After Treatment J Yu, B Xu, G Ma, Y Liu, Y Yang, J Xu, M Sun Endocrine Practice 30 (1), 19-24, 2024 | 1 | 2024 |
| NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1 Z Zhang, B Song, H Wei, Y Liu, W Zhang, Y Yang, B Sun Drug Resistance Updates 73, 101040, 2024 | | 2024 |
| Genes mediating cell growth in aldosterone-producing adenomas Y Yang, M Tetti, P Mulatero, H Schneider, M Reincke, WT Ann Endocrine Abstracts 70, 2020 | | 2020 |
| Role of KCNJ5 mutations in mediating cell growth in aldosterone-producing adenomas Y Yang, LS Meyer, D Jaquin, H Schneider, M Ploncynski, F Beuschlein, ... Endocrine Abstracts 63, 2019 | | 2019 |
| Identification of genes mediating dysregulated cell growth in aldosterone-producing adenomas Y Yang, M Tetti, D Jaquin, P Mulatero, H Schneider, F Beuschlein, ... Endocrine Abstracts 63, 2019 | | 2019 |
Martin Reincke Ludwig-Maximilians-Universität MünchenVerifierad e-postadress på med.uni-muenchen.de
